1. Home
  2. ARMP vs QRHC Comparison

ARMP vs QRHC Comparison

Compare ARMP & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • QRHC
  • Stock Information
  • Founded
  • ARMP N/A
  • QRHC N/A
  • Country
  • ARMP United States
  • QRHC United States
  • Employees
  • ARMP N/A
  • QRHC N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • QRHC Environmental Services
  • Sector
  • ARMP Health Care
  • QRHC Utilities
  • Exchange
  • ARMP Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • ARMP 52.1M
  • QRHC 44.7M
  • IPO Year
  • ARMP N/A
  • QRHC N/A
  • Fundamental
  • Price
  • ARMP $1.91
  • QRHC $2.23
  • Analyst Decision
  • ARMP Strong Buy
  • QRHC Strong Buy
  • Analyst Count
  • ARMP 1
  • QRHC 2
  • Target Price
  • ARMP $9.00
  • QRHC $12.75
  • AVG Volume (30 Days)
  • ARMP 36.4K
  • QRHC 87.8K
  • Earning Date
  • ARMP 08-12-2025
  • QRHC 08-07-2025
  • Dividend Yield
  • ARMP N/A
  • QRHC N/A
  • EPS Growth
  • ARMP N/A
  • QRHC N/A
  • EPS
  • ARMP N/A
  • QRHC N/A
  • Revenue
  • ARMP $4,699,000.00
  • QRHC $284,311,000.00
  • Revenue This Year
  • ARMP $8.43
  • QRHC $4.34
  • Revenue Next Year
  • ARMP N/A
  • QRHC $6.28
  • P/E Ratio
  • ARMP N/A
  • QRHC N/A
  • Revenue Growth
  • ARMP 14.24
  • QRHC N/A
  • 52 Week Low
  • ARMP $0.90
  • QRHC $1.91
  • 52 Week High
  • ARMP $3.42
  • QRHC $9.25
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 52.83
  • QRHC 48.16
  • Support Level
  • ARMP $1.74
  • QRHC $2.03
  • Resistance Level
  • ARMP $2.00
  • QRHC $2.23
  • Average True Range (ATR)
  • ARMP 0.15
  • QRHC 0.12
  • MACD
  • ARMP -0.03
  • QRHC 0.01
  • Stochastic Oscillator
  • ARMP 43.59
  • QRHC 74.29

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

Share on Social Networks: